{"id":"W2763770778","doi":"10.1093/annonc/mdx368","title":"Pembrolizumab for patients with PD-L1–positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Neuroendocrine tumors; Internal medicine; Carcinoid syndrome; Clinical endpoint; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Carcinoid tumors; Phases of clinical research; Toxicity; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001994864,0.000334263,0.0009891457,0.0001026722,0.0004242602,0.00004024163,0.0007124877,0.00001381378,0.00003245232],"category_scores_gemma":[0.006095236,0.0001908294,0.0001366194,0.0001254961,0.0005179325,0.0002834511,0.0003036456,0.0003868191,0.00001162686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005395478,"about_ca_system_score_gemma":0.0004066465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009327431,"about_ca_topic_score_gemma":0.0007400747,"domain_scores_codex":[0.9969706,0.0003055855,0.0006584959,0.0007045476,0.0005979452,0.0007628208],"domain_scores_gemma":[0.9942476,0.002318372,0.0007567484,0.001487122,0.0009424161,0.0002477605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5019009,0.01125092,0.3960504,0.0002408695,0.001156377,0.01391979,0.001672601,0.00005840051,0.001107287,0.00008457238,0.01415319,0.05840471],"study_design_scores_gemma":[0.03852824,0.07882246,0.8642873,0.0001999575,0.0002366454,0.000175041,0.0007709307,0.00003413481,0.005837601,0.0001783637,0.01070056,0.0002287735],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819473,0.00008671829,0.000005973021,0.01162235,0.0001542542,0.0040346,0.0006107226,0.00003920371,0.001498858],"genre_scores_gemma":[0.9966004,0.0001245805,0.0004617091,0.001129723,0.0002223002,0.0003388916,0.0001175073,0.00006048647,0.0009443243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4682369,"threshold_uncertainty_score":0.7781798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07114646937290031,"score_gpt":0.4065153330562797,"score_spread":0.3353688636833794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}